Companies /Real Estate

Ventas Inc

NYSE: VTR Reit - Healthcare Facilities
$90.27
▼ $1.84 (−2.00%) today
Markets closed · 7:23am ET

Q1 2025 Earnings

Reported Apr 30, 2025, 4:33pm ET · SEC source
$0.84
Beat +0.00%
EPS · est. $0.00
$1.4B
Beat +3.25%
Revenue · est. $1.3B
−10.2%
Trailing market
VTR vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−6%−3%0Apr 30May 1report 4:33pm ETearnings+0.7%−6.3%
−6%−3%0Apr 30May 1earnings+0.7%−6.3%
VTR −6.3%S&P 500 +0.7%
−6%−3%0+3%Apr 30May 1report 4:33pm ETearnings+1.2%−6.3%
−6%−3%0+3%Apr 30May 1earnings+1.2%−6.3%
VTR −6.3%NASDAQ +1.2%
−6%−3%0+3%Apr 29May 8report 4:33pm ETearnings+1.9%−6.3%
−6%−3%0+3%Apr 29May 8earnings+1.9%−6.3%
VTR −6.3%S&P 500 +1.9%
−4%0+4%Apr 29May 8report 4:33pm ETearnings+2.7%−6.3%
−4%0+4%Apr 29May 8earnings+2.7%−6.3%
VTR −6.3%NASDAQ +2.7%
−6.48%
Day of report
+1.56%
Next session
+0.06%
One week
−3.49%
30 days

S&P 500 over the same 30 days: +6.74%.

Did VTR Beat Earnings? Q1 2025 Results

Ventas posted a strong first quarter of 2025, with total revenues climbing 13.2% year-over-year to $1.36 billion, beating consensus estimates of $1.32 billion by 3.25%, as the healthcare REIT continued to capitalize on what CEO Debra Cafaro has called an "unprecedented multiyear growth opportunity" in senior housing. Normalized FFO came in at $0.84 per share, reflecting approximately 8% year-over-year growth, while net income attributable to common stockholders turned positive at $0.10 per diluted share, compared to a loss of $0.04 in the year-ago period. The primary engine behind the beat was the senior housing operating portfolio, where same-store cash NOI surged 13.6% year-over-year on 290 basis points of occupancy expansion and RevPOR growth of 3.8%. Ventas also raised its full-year senior housing investment target to $1.50 billion from $1.00 billion, having already closed roughly $900.00 million in acquisitions, while reaffirming its full-year Normalized FFO guidance of $3.35 to $3.46 per share, representing 5-8% year-over-year growth.

Key Takeaways
  • SHOP same-store cash NOI grew 13.6% year-over-year driven by 7.4% revenue growth
  • SHOP same-store average occupancy grew 290 basis points year-over-year
  • U.S. SHOP average occupancy growth of 330 basis points year-over-year
  • RevPOR growth of 3.8% year-over-year (5.0% adjusted for leap year impact)
  • SHOP NOI margin growth of 150 basis points
  • Total Company NOI year-over-year growth of approximately 13%
  • Total Company Same-Store Cash NOI year-over-year growth of approximately 7%

“Ventas delivered a strong first quarter of 2025, as we executed on our strategy to capitalize on the unprecedented multiyear growth opportunity in senior housing. We drove double-digit growth in our senior housing operating portfolio (SHOP), which powered our first quarter results.”

Ventas CEO, on the earnings call

Forward Guidance & Outlook

Ventas reaffirmed its full-year 2025 guidance with Normalized FFO per share of $3.35-$3.46 (midpoint $3.41), representing 5-8% year-over-year growth. Attributable Net Income per share is expected at $0.42-$0.53. The company increased its 2025 senior housing investment volume guidance to $1.5 billion from $1 billion, with incremental investments expected to be second-half weighted and funded primarily with existing unsettled forward equity commitments and disposition proceeds. Net disposition proceeds are expected at approximately $200 million. Full year weighted average diluted share count increased from 456 million to 460 million. Net interest expense is expected to increase approximately $32 million year-over-year due to refinancing maturing debt at higher rates and lower cash balances.

VTR YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$400.0M$800.0M$1.2B$1.2B$1.4BRevenue$9.0M$48.4MNet Income
$0$400.0M$800.0M$1.2BRevenueNet Income

VTR Revenue by Segment

Senior Housing Operating Portfolio (SHOP)
Outpatient Medical and Research (OM&R)
Triple-Net Leased Properties (NNN)

Figures from SEC filings and company reports. Not investment advice.